247 related articles for article (PubMed ID: 15866321)
1. WNK kinases and the control of blood pressure.
Cope G; Golbang A; O'Shaughnessy KM
Pharmacol Ther; 2005 May; 106(2):221-31. PubMed ID: 15866321
[TBL] [Abstract][Full Text] [Related]
2. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of regulation of renal ion transport by WNK kinases.
Huang CL; Yang SS; Lin SH
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
[TBL] [Abstract][Full Text] [Related]
4. WNK kinases and essential hypertension.
Huang CL; Kuo E; Toto RD
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):133-7. PubMed ID: 18277144
[TBL] [Abstract][Full Text] [Related]
5. WNK kinases: molecular regulators of integrated epithelial ion transport.
Kahle KT; Wilson FH; Lalioti M; Toka H; Qin H; Lifton RP
Curr Opin Nephrol Hypertens; 2004 Sep; 13(5):557-62. PubMed ID: 15300163
[TBL] [Abstract][Full Text] [Related]
6. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension.
Gamba G
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F245-52. PubMed ID: 15637347
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.
Golbang AP; Cope G; Hamad A; Murthy M; Liu CH; Cuthbert AW; O'shaughnessy KM
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1369-76. PubMed ID: 16788137
[TBL] [Abstract][Full Text] [Related]
8. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
9. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
10. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
[TBL] [Abstract][Full Text] [Related]
11. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM
Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707
[TBL] [Abstract][Full Text] [Related]
12. WNK kinases regulate sodium chloride and potassium transport by the aldosterone-sensitive distal nephron.
Subramanya AR; Yang CL; McCormick JA; Ellison DH
Kidney Int; 2006 Aug; 70(4):630-4. PubMed ID: 16820787
[TBL] [Abstract][Full Text] [Related]
13. WNK kinases, renal ion transport and hypertension.
San-Cristobal P; de los Heros P; Ponce-Coria J; Moreno E; Gamba G
Am J Nephrol; 2008; 28(5):860-70. PubMed ID: 18547946
[TBL] [Abstract][Full Text] [Related]
14. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
15. WNK kinases influence TRPV4 channel function and localization.
Fu Y; Subramanya A; Rozansky D; Cohen DM
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1305-14. PubMed ID: 16403833
[TBL] [Abstract][Full Text] [Related]
16. Intersectin links WNK kinases to endocytosis of ROMK1.
He G; Wang HR; Huang SK; Huang CL
J Clin Invest; 2007 Apr; 117(4):1078-87. PubMed ID: 17380208
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of type I and type II pseudohypoaldosteronism.
Furgeson SB; Linas S
J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.
Hadchouel J; Ellison DH; Gamba G
Annu Rev Physiol; 2016; 78():367-89. PubMed ID: 26863326
[TBL] [Abstract][Full Text] [Related]
19. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population.
Kokubo Y; Kamide K; Inamoto N; Tanaka C; Banno M; Takiuchi S; Kawano Y; Tomoike H; Miyata T
J Hum Genet; 2004; 49(9):507-515. PubMed ID: 15309683
[TBL] [Abstract][Full Text] [Related]
20. Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome.
Xie J; Craig L; Cobb MH; Huang CL
Pediatr Nephrol; 2006 Sep; 21(9):1231-6. PubMed ID: 16683163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
